Home/Filings/4/0001209191-16-126262
4//SEC Filing

Hatteras Venture Partners IV SBIC, LP 4

Accession 0001209191-16-126262

CIK 0001539029other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:35 PM ET

Size

33.0 KB

Accession

0001209191-16-126262

Insider Transaction Report

Form 4
Period: 2016-06-07
Crumpler John
10% Owner
Transactions
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
Transactions
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
Transactions
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
Transactions
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
Transactions
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
Transactions
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
Thorp Clay
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2016-06-07$0.02/sh+21,705$4781,675,953 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Purchase

    Common Stock

    2016-06-07$7.00/sh+414,286$2,900,0022,090,170 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Sale

    Common Stock

    2016-06-07$7.00/sh69$4831,675,884 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A-1 Preferred Stock

    2016-06-07689,3880 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (313,358 underlying)
  • Conversion

    Series C Preferred Stock

    2016-06-07337,8970 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (162,662 underlying)
  • Exercise of In-Money

    Warrant to Purchase Common Stock (right to buy)

    2016-06-0721,7050 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Exercise: $0.02From: 2014-04-28Common Stock (21,705 underlying)
  • Conversion

    Common Stock

    2016-06-07+1,598,2231,654,248 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
  • Conversion

    Series A Preferred Stock

    2016-06-072,035,9080 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (925,412 underlying)
  • Conversion

    Series B Preferred Stock

    2016-06-07432,9410 total(indirect: By Hatteras Venture Partners IV SBIC, LP)
    Common Stock (196,791 underlying)
Footnotes (5)
  • [F1]The total represents shares received upon conversion of shares of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock.
  • [F2]Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock automatically converted into 0.454545 shares of the Issuer's common stock, and each share of Series C Preferred Stock automatically converted into 0.4814 shares of the Issuer's common stock. The Preferred Stock had no expiration date.
  • [F3]The reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC is the general partner of HVP IV (the "GP"). The securities directly held by HVP IV are indirectly held by the individual managing members of GP (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
  • [F4]On June 7, 2016, HVP IV exercised a warrant to purchase 21,705 shares of Issuer's common stock for $0.022 per share. HVP IV paid the exercise price on a cashless basis, resulting in the Issuer's withholding of an aggregate of 69 of the warrant shares to pay the exercise price and issuing to the HVP IV the remaining 21,636 shares.
  • [F5]This warrant would have expired upon the closing of the Issuer's initial public offering.

Issuer

Clearside Biomedical, Inc.

CIK 0001539029

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001675232

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:35 PM ET
Size
33.0 KB